Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Drug metabolome of the simvastatin formed by human intestinal microbiota in vitro

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Probing protein phosphatase substrate binding: affinity pull-down of ILKAP phosphatase 2C with phosphopeptides

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Circulating metabolites in progression to islet autoimmunity and type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Polyols and Branched Chained Amino Acids Are Associated with Present and Future Renal Impairment in Type 1 Diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Circulating metabolites are associated with present and future renal impairment in type 1 Diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • Anna-Marja Aura
  • Ismo Mattila
  • Tuulia Hyötyläinen
  • Peddinti Gopalacharyulu
  • Catherine Bounsaythip
  • Matej Orešič
  • Kirsi-Marja Oksman-Caldentey
View graph of relations

The human colon contains a diverse microbial population which contributes to degradation and metabolism of food components. Drug metabolism in the colon is generally poorly understood. Metabolomics techniques and in vitro colon models are now available which afford detailed characterization of drug metabolites in the context of colon metabolism. The aim of this work was to identify novel drug metabolites of Simvastatin (SV) by using an anaerobic human in vitro colon model at body temperature coupled with systems biology platform, excluding the metabolism of the host liver and intestinal epithelia. Comprehensive two-dimensional gas chromatography with a time-of-flight mass spectrometry (GC×GC-TOFMS) was used for the metabolomic analysis. Metabolites showing the most significant differences in the active faecal suspension were elucidated in reference with SV fragmentation and compared with controls: inactive suspension or buffer with SV, or with active suspension alone. Finally, time courses of selected metabolites were investigated. Our data suggest that SV is degraded by hydrolytic cleavage of methylbutanoic acid from the SV backbone. Metabolism involves demethylation of dimethylbutanoic acid, hydroxylation/dehydroxylation and β-oxidation resulting in the production of 2-hydroxyisovaleric acid (3-methyl-2-hydroxybutanoic acid), 3-hydroxybutanoic acid and lactic acid (2-hydroxypropanoic acid), and finally re-cyclisation of heptanoic acid (possibly de-esterified and cleaved methylpyranyl arm) to produce cyclohexanecarboxylic acid. Our study elucidates a pathway of colonic microbial metabolism of SV as well as demonstrates the applicability of the in vitro colon model and metabolomics to the discovery of novel drug metabolites from drug response profiles.

Original languageEnglish
JournalMolecular BioSystems
Volume7
Issue number2
Pages (from-to)437-46
Number of pages10
ISSN1742-206X
DOIs
Publication statusPublished - Feb 2011
Externally publishedYes

    Research areas

  • Colon/microbiology, Gas Chromatography-Mass Spectrometry, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism, In Vitro Techniques, Metabolome, Models, Biological, Simvastatin/metabolism

ID: 54987263